Phase III KEYNOTE-204: Pembrolizumab vs Brentuximab Vedotin in Relapsed/Refractory Classical Hodgkin Lymphoma

May 29-31, 2020; Online at meetings.asco.org/am
Pembrolizumab significantly improved PFS in patients with relapsed/refractory cHL vs brentuximab vedotin, including those ineligible for ASCT, with primary refractory disease, and who were brentuximab vedotin naive.
Format: Microsoft PowerPoint (.ppt)
File Size: 259 KB
Released: June 9, 2020

Acknowledgements

Provided by Clinical Care Options, LLC.

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
AbbVie Inc.
AstraZeneca
Bristol-Myers Squibb
GlaxoSmithKline
Karyopharm Therapeutics

Related Content

Free video from Clinical Care Options featuring expert discussion of the latest updates in CAR T-cell therapy for hematologic cancers

Michael R. Bishop, MD
Program Director
Daniel J. DeAngelo, MD, PhD Noopur Raje, MD
Physicians: maximum of 1.5 AMA PRA Category 1 Credits ABIM MOC: maximum of 1.5 Medical Knowledge MOC point(s) Released: August 14, 2020 Expired: August 13, 2021

Dr. Jacqueline Barrientos shares her experiences managing patients with CLL during the COVID-19 pandemic in NYC and offers recommendations, from CCO

Jacqueline Barrientos, MD, MS Released: August 11, 2020

Downloadable summary slideset with a quick summary of the current treatment algorithm for CLL, from Clinical Care Options.

Farrukh T. Awan, MD Ian W. Flinn, MD, PhD Released: August 5, 2020

John M. Burke, MD Released: August 4, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?